Li-Taka Enters Into Manufacturing Agreement With Wockhardt

Li-Taka Pharmaceuticals, a Pune-based Pharmaceutical Formulation Company, has recently entered into a manufacturing agreement with Wockhardt for manufacturing of Anti-TB range of products. The company is expected to receive incremental revenue of over Rs 6 million from this year, which shall further boost its revenues. The company is already specialized in the manufacture of Anti-TB range of products for large, multinational and Indian companies, such as Novartis, Cipla, Emcure and Lupin, in the Anti-TB segment and this agreement with Wockhardt will add to the list of reputed clients for its contracts manufacturing business, Li-Taka said in a release.

PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25847§ionid=)